Latest Ambu News & Updates

See the latest news and media coverage for Ambu. We track all announcements, press releases, and industry mentions in real time, all in one place.

Ambu

Manufacturer of single-use medical devices

ambu.com

Headquarters: Ballerup, Denmark
Founded year: 1937
Company type: Public company
Number of employees: 5,000–10,000
Industry: Medical Equipment, Supplies & Distribution

Last updated Today

Latest news about Ambu

In short: Ambu launched its ZOOM AHEAD strategy, updated financial guidance, and executed extensive share buyback programs to return capital.

Company announcements

August 25 Ambu

Ambu updates its fiscal 2025/26 financial outlook guidance

The company expects around ten percent organic revenue growth and an EBIT margin between twelve and fourteen percent, driven primarily by its Endoscopy Solutions segment.

August 20 Ambu

Ambu receives FDA and CE clearance for new Ambu Neuroline Cup MRI/CT solution

The new device supports uninterrupted brain activity monitoring for critically ill patients during MRI and CT scans, simplifying EEG workflows.

May 18 Ambu

Ambu repurchases 548,623 shares in buyback program

The transactions from 11 to 13 May 2026 totaled DKK 34.2m at an average price of DKK 62.27.

May 7 Ambu

Ambu discloses CFO share purchase

Henrik Skak Bender bought 10,000 shares at DKK 62.2 on May 7, 2026, on Nasdaq Copenhagen.

Media coverage

Yesterday Yahoo Finance

UBS becomes more cautious on Ambu, believing that profit margin targets are difficult to achieve

Investing.com - UBS downgraded the rating of Danish medical device manufacturer Ambu A/S from 'Buy' to 'Neutral', and lowered its 12-month target price from 96 Danish kroner to 72 Danish kroner, citing repeated resets of the company's earnings forecasts and a lack of sufficient justification for management's set profit margin targets...

September 14 Børsen

Ambu buys Tims Medical for a seven-figure sum

Ambu is expanding its business in endoscopy with the acquisition of American Foresight Imaging, behind the company Tims Medical. The Danish medical group pays DKK 45 million...

September 9 Marketscreener

JP Morgan downgrades Coloplast - puts Ambu and Elekta on negative watchlist - BN

JP Morgan has downgraded the medical technology company Coloplast to Underweight with a target price of 377 Danish kroner and simultaneously placed Ambu and Elekta on negative watch ahead of potentially...

August 28 Ad hoc news

Ambu stock stabilizes after guidance cut as Q3 2026 earnings show improving margins

Ambu stock is attempting to regain footing after a late-August guidance cut, with Q3 2026 earnings showing revenue growth, higher EPS and stronger margins despite...

Never miss news about Ambu

Track Ambu and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Ambu competitors & trending companies

Browse news for competitors to Ambu and other trending companies.